Targeting microRNAs in cancer: rationale, strategies and challenges
- PMID: 20885409
- PMCID: PMC3904431
- DOI: 10.1038/nrd3179
Targeting microRNAs in cancer: rationale, strategies and challenges
Abstract
MicroRNAs (miRNAs) are evolutionarily conserved small non-coding RNAs that regulate gene expression. Early studies have shown that miRNA expression is deregulated in cancer and experimental data indicate that cancer phenotypes can be modified by targeting miRNA expression. Based on these observations, miRNA-based anticancer therapies are being developed, either alone or in combination with current targeted therapies, with the goal to improve disease response and increase cure rates. The advantage of using miRNA approaches is based on its ability to concurrently target multiple effectors of pathways involved in cell differentiation, proliferation and survival. In this Review, we describe the role of miRNAs in tumorigenesis and critically discuss the rationale, the strategies and the challenges for the therapeutic targeting of miRNAs in cancer.
Figures
Similar articles
-
MicroRNAs as therapeutic targets in human cancers.Wiley Interdiscip Rev RNA. 2014 Jul-Aug;5(4):537-48. doi: 10.1002/wrna.1229. Epub 2014 Mar 28. Wiley Interdiscip Rev RNA. 2014. PMID: 24687772 Free PMC article. Review.
-
MicroRNAs as anti-cancer therapy.Curr Pharm Des. 2014;20(33):5328-35. doi: 10.2174/1381612820666140128211346. Curr Pharm Des. 2014. PMID: 24479801 Review.
-
MicroRNAs and cancer therapy - from bystanders to major players.Curr Med Chem. 2013;20(29):3561-73. doi: 10.2174/0929867311320290002. Curr Med Chem. 2013. PMID: 23834177 Review.
-
microRNAs as pharmacological targets in cancer.Pharmacol Res. 2013 Sep;75:3-14. doi: 10.1016/j.phrs.2013.03.006. Epub 2013 Mar 25. Pharmacol Res. 2013. PMID: 23537752 Review.
-
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.EMBO Mol Med. 2012 Mar;4(3):143-59. doi: 10.1002/emmm.201100209. Epub 2012 Feb 20. EMBO Mol Med. 2012. PMID: 22351564 Free PMC article. Review.
Cited by
-
Molecular and Therapeutic Roles of Non-Coding RNAs in Oral Cancer-A Review.Molecules. 2024 May 20;29(10):2402. doi: 10.3390/molecules29102402. Molecules. 2024. PMID: 38792263 Free PMC article. Review.
-
Coexistence of liver abscess, hepatic cystic echinococcosis and hepatocellular carcinoma: A case report.World J Clin Cases. 2024 May 16;12(14):2404-2411. doi: 10.12998/wjcc.v12.i14.2404. World J Clin Cases. 2024. PMID: 38765738 Free PMC article.
-
Chemical modification patterns for microRNA therapeutic mimics: a structure-activity relationship (SAR) case-study on miR-200c.Nucleic Acids Res. 2024 Apr 12;52(6):2792-2807. doi: 10.1093/nar/gkae141. Nucleic Acids Res. 2024. PMID: 38421619 Free PMC article.
-
Updates on the role of epigenetics in familial mediterranean fever (FMF).Orphanet J Rare Dis. 2024 Feb 26;19(1):90. doi: 10.1186/s13023-024-03098-w. Orphanet J Rare Dis. 2024. PMID: 38409042 Free PMC article. Review.
-
Advances in Research Related to MicroRNA for Diabetic Retinopathy.J Diabetes Res. 2024 Feb 12;2024:8520489. doi: 10.1155/2024/8520489. eCollection 2024. J Diabetes Res. 2024. PMID: 38375094 Free PMC article. Review.
References
-
- Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–355. - PubMed
-
- Lee Y, Ahn C, Han J, Choi H, Kim J. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415–419. - PubMed
-
- Landthaler M, Yalcin A, Tuschl T. The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr. Biol. 2004;14:2162–2167. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources